Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Public Offering
Private Placement
Equity Line Of Credit
Preferred Stock
Preferred Stock
Public Offering
Common Stock
Common Stock
Public Offering
Common Stock
Private Placement
Common Stock
Equity Line Of Credit
Additional Paid-In Capital
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Equity Line Of Credit
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022         7   199,608                  
Beginning balance at Dec. 31, 2022 $ 11,407,600       $ 0   $ 17,986       $ 146,035,314       $ (134,462,959) $ (182,741)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 572,600                   572,600          
Issuance of common stock (in shares)           3,908   244,181 5,866 13,889            
Issuance of Common Stock   $ 5,595,962 $ 115,715 $ 442,312   $ 39   $ 21,976 $ 528 $ 1,250   $ 5,573,947 $ 115,187 $ 441,062    
Issuance of Common Stock from Warrant Exercises (in shares)             5,556                  
Issuance of Common Stock from Warrant Exercises 298,500           $ 500       298,000          
Conversion of Preferred Stock into Common Stock (in shares)         (3,488)   352,288                  
Conversion of Preferred Stock into Common Stock 0       $ (34)   $ 31,707       (31,673)          
Issuance of Common Stock from Restricted Stock Awards (in shares)             32,972                  
Issuance of Common Stock from Restricted Stock Awards 0           $ 2,968       (2,968)          
Unrealized Gain on Marketable Securities 0                              
Foreign Currency Translation Adjustment (83,430)                             (83,430)
Net Income (Loss) (10,245,290)                           (10,245,290)  
Ending balance (in shares) at Sep. 30, 2023         427   854,360                  
Ending balance at Sep. 30, 2023 8,103,969       $ 5   $ 76,915       153,001,469       (144,708,249) (266,171)
Beginning balance (in shares) at Jun. 30, 2023         957   767,858                  
Beginning balance at Jun. 30, 2023 13,642,355       $ 10   $ 69,129       152,744,385       (138,945,308) (225,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 264,865                   264,865          
Conversion of Preferred Stock into Common Stock (in shares)         (530)   53,530                  
Conversion of Preferred Stock into Common Stock 0       $ (5)   $ 4,818       (4,813)          
Issuance of Common Stock from Restricted Stock Awards (in shares)             32,972                  
Issuance of Common Stock from Restricted Stock Awards 0           $ 2,968       (2,968)          
Unrealized Gain on Marketable Securities 0                              
Foreign Currency Translation Adjustment (40,310)                             (40,310)
Net Income (Loss) (5,762,941)                           (5,762,941)  
Ending balance (in shares) at Sep. 30, 2023         427   854,360                  
Ending balance at Sep. 30, 2023 8,103,969       $ 5   $ 76,915       153,001,469       (144,708,249) (266,171)
Beginning balance (in shares) at Dec. 31, 2023         427   856,182                  
Beginning balance at Dec. 31, 2023 6,109,654       $ 4   $ 77,078       153,192,228       (146,976,855) (182,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 496,413                   496,413          
Issuance of common stock (in shares)             1,755,556                  
Issuance of Common Stock 13,808,816           $ 158,000       13,650,816          
Issuance of Common Stock from Warrant Exercises (in shares)             358,831                  
Issuance of Common Stock from Warrant Exercises 1,689,339           $ 32,295       1,657,044          
Adjustments Due to the Rounding Impact from the Reverse Stock Split for Fractional Shares (in shares)             (385)                  
Issuance of Common Stock from Restricted Stock Awards (in shares)             30,604                  
Issuance of Common Stock from Restricted Stock Awards 0           $ 306       (306)          
Unrealized Gain on Marketable Securities 73,607                             73,607
Foreign Currency Translation Adjustment 33,988                             33,988
Net Income (Loss) 7,818,235                           7,818,235  
Ending balance (in shares) at Sep. 30, 2024         427   3,000,788                  
Ending balance at Sep. 30, 2024 30,030,052       $ 4   $ 267,679       168,996,195       (139,158,620) (75,206)
Beginning balance (in shares) at Jun. 30, 2024         427   2,970,545                  
Beginning balance at Jun. 30, 2024 33,101,673       $ 4   $ 267,373       168,825,325       (135,745,294) (245,735)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 171,176                   171,176          
Adjustments Due to the Rounding Impact from the Reverse Stock Split for Fractional Shares (in shares)             (361)                  
Issuance of Common Stock from Restricted Stock Awards (in shares)             30,604                  
Issuance of Common Stock from Restricted Stock Awards 0           $ 306       (306)          
Unrealized Gain on Marketable Securities 76,435                             76,435
Foreign Currency Translation Adjustment 94,094                             94,094
Net Income (Loss) (3,413,326)                           (3,413,326)  
Ending balance (in shares) at Sep. 30, 2024         427   3,000,788                  
Ending balance at Sep. 30, 2024 $ 30,030,052       $ 4   $ 267,679       $ 168,996,195       $ (139,158,620) $ (75,206)